​

CervoMed (CRVO) Stock Forecast, Price Target & Predictions

OverviewRevenueFinancialsChart

CRVO Stock Forecast

CervoMed (CRVO) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $16.32, with a high of $16.32 and a low of $16.32. This represents a 606.49% increase from the last price of $2.31.

- $5 $10 $15 $20 $25 High: $16.32 Avg: $16.32 Low: $16.32 Last Closed Price: $2.31

CRVO Stock Rating

CervoMed stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (50.00%), 1 Hold (25.00%), 1 Sell (25.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 1 1 2 Strong Sell Sell Hold Buy Strong Buy

CRVO Price Target Upside V Benchmarks

TypeNameUpside
StockCervoMed606.49%
SectorHealthcare Stocks 25.00%
IndustryBiotech Stocks 63.52%

Price Target Trends

1M3M12M
# Anlaysts--3
Avg Price Target--$17.31
Last Closing Price$2.31$2.31$2.31
Upside/Downside--649.35%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 251151-8
Jan, 251151-8
Dec, 243551-14
Nov, 2415---6
Oct, 2414---5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 18, 2024Danill GataulinLoop Capital Markets$16.32$4.79240.71%606.49%
Sep 18, 2024Daniil GataulinChardan Capital$16.32$4.79240.71%606.49%
Apr 08, 2024Sumant KulkarniCanaccord Genuity$19.29$6.08217.27%735.06%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 17, 2024H.C. WainwrightBuyNeutraldowngrade
Dec 11, 2024Morgan StanleyOverweightUnderweightdowngrade
Sep 18, 2024Chardan CapitalBuyinitialise
Jul 26, 2024Morgan StanleyOverweightinitialise
Apr 08, 2024Canaccord GenuityBuyBuyhold
Aug 16, 2022H.C. WainwrightBuyupgrade

Financial Forecast

EPS Forecast

$-8 $-7 $-6 $-5 $-4 $-3 $-2 $-1 $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.82-----
Avg Forecast$-3.57$-1.85$-1.64$-2.20$-1.26$-1.36
High Forecast$-7.46$-2.08$-2.12$-4.61$-2.64$-2.85
Low Forecast$-0.82$-1.58$-1.18$-0.50$-0.29$-0.31
Surprise %-77.03%-----

Revenue Forecast

$0 $3M $6M $9M $12M $15M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.14M-----
Avg Forecast$4.35M$8.05M$4.81M$7.14M$7.14M$5.20M
High Forecast$1.77M$7.07M$2.22M$2.91M$2.91M$2.12M
Low Forecast$8.01M$9.61M$6.89M$13.16M$13.16M$9.57M
Surprise %64.25%-----

Net Income Forecast

$-20M $-16M $-12M $-8M $-4M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.17M-----
Avg Forecast$-11.02M$-4.88M$-4.39M$-6.81M$-3.89M$-3.62M
High Forecast$-19.86M$-5.54M$-5.64M$-12.28M$-7.02M$-7.58M
Low Forecast$-2.17M$-4.21M$-3.14M$-1.34M$-767.90K$-828.85K
Surprise %-80.29%-----

CRVO Forecast FAQ

Is CervoMed stock a buy?

CervoMed stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 1 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that CervoMed is a favorable investment for most analysts.

What is CervoMed's price target?

CervoMed's price target, set by 4 Wall Street analysts, averages $16.32 over the next 12 months. The price target range spans from $16.32 at the low end to $16.32 at the high end, suggesting a potential 606.49% change from the previous closing price of $2.31.

How does CervoMed stock forecast compare to its benchmarks?

CervoMed's stock forecast shows a 606.49% upside, outperforming the average forecast for the healthcare stocks sector (25.00%) and outperforming the biotech stocks industry (63.52%).

What is the breakdown of analyst ratings for CervoMed over the past three months?

  • February 2025: 12.50% Strong Buy, 12.50% Buy, 62.50% Hold, 12.50% Sell, 0% Strong Sell.
  • January 2025: 12.50% Strong Buy, 12.50% Buy, 62.50% Hold, 12.50% Sell, 0% Strong Sell.
  • December 2024: 21.43% Strong Buy, 35.71% Buy, 35.71% Hold, 7.14% Sell, 0% Strong Sell.

What is CervoMed’s EPS forecast?

CervoMed's average annual EPS forecast for its fiscal year ending in December is $-1.85 for 2024, a 125.61% increase from the reported $-0.82 in 2023. The prediction for 2025 is $-1.64, $-2.2 for 2026, $-1.26 for 2027, and $-1.36 for 2028.

What is CervoMed’s revenue forecast?

CervoMed's average annual revenue forecast for its fiscal year ending in December is $8.05M for 2024, a 12.68% increase from the reported $7.14M in 2023. The forecast for 2025 is $4.81M, $7.14M for 2026, $7.14M for 2027, and $5.2M for 2028.

What is CervoMed’s net income forecast?

For its fiscal year ending in December, CervoMed's average annual net income forecast is $-4.878M for 2024, reflecting an 124.59% increase from the reported $-2.172M in 2023. The projection for 2025 is $-4.39M, $-6.81M for 2026, $-3.894M for 2027, and $-3.62M for 2028.